News

NeuExcell Therapeutics and Spark Therapeutics, a member of the Roche Group announced a gene therapy collaboration aimed at developing a safe and effective treatment for patients suffering from Huntington's Disease (HD). Under the terms of the agreement, Spark Therapeutics will...

Following the International Sustainability and Carbon Certificate (ISCC) Plus accreditation of its Berry Astra Plastique facility in Saint-Georges-de-Reneins, France, Berry Healthcare’s market-leading Vistop® PP36 patented tamper evident closure for autoclave sterilisation can now be specified incorporating advanced recycling resin...

Genezen Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has appointed Ray Kaczmarek as CEO. Mr. Kaczmarek has over 28 years of leadership experience with the past 20 years in pharmaceutical and biotechnology manufacturing and supply...

CEVEC Pharmaceuticals GmbH announced the signing of an agreement with UCB S.A. on the evaluation and use of CEVEC’s proprietary ELEVECTA® Technology for the research, development, and manufacturing of Adeno-Associated Virus (AAV) vectors for gene therapy applications. According to the...

Arecor Therapeutics plc, a biopharmaceutical group advancing therapies to enable healthier lives, has signed a formulation agreement with Intas Pharmaceuticals Ltd. Under this agreement, Arecor will use its proprietary formulation technology platform Arestat to develop a differentiated product for Intas....

DoKaSch Temperature Solutions has opened a new service station in India. It is located at GMR Hyderabad Air Cargo terminal. Strategically, the Hyderabad Airport location is a very important network station for the global supply of lifesaving medicines given Hyderabad’s...

Indian drug developer Hetero said it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's (ROG.S) COVID-19 drug. Hetero expects to make the treatment, tocilizumab, available in India by the...